Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Gilead Sciences
(NQ:
GILD
)
147.23
-4.45 (-2.93%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 10, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
10,787,106
Open
151.47
Bid (Size)
144.80 (100)
Ask (Size)
145.48 (100)
Prev. Close
151.68
Today's Range
147.07 - 151.87
52wk Range
93.37 - 153.13
Shares Outstanding
1,253,809,440
Dividend Yield
2.15%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Gilead (GILD) Q4 2025 Earnings Call Transcript
↗
February 10, 2026
Gilead (GILD) Q4 2025 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
Gilead Sciences Inc (NASDAQ:GILD) Posts Strong Q4 Beat but 2026 Outlook Disappoints
↗
February 10, 2026
Via
Chartmill
Performance
YTD
+21.1%
+21.1%
1 Month
+20.1%
+20.1%
3 Month
+20.1%
+20.1%
6 Month
+22.7%
+22.7%
1 Year
+54.2%
+54.2%
More News
Read More
Gilead Stock Slips After Q4 Earnings, Weak FY26 Guidance
↗
February 10, 2026
Via
Benzinga
Gilead Sciences’s (NASDAQ:GILD) Q4 CY2025 Sales Beat Estimates
February 10, 2026
Via
StockStory
Topics
Earnings
Will Gilead's Solid Fourth Quarter Be Enough To Shake Off Its Light Outlook?
↗
February 10, 2026
Via
Investor's Business Daily
Gilead Sciences Inc. (NASDAQ:GILD) Passes the Caviar Cruise Quality Investing Screen
↗
January 22, 2026
Via
Chartmill
Gilead Sciences Announces 3.8 Percent Increase in First Quarter 2026 Dividend
February 10, 2026
From
Gilead Sciences, Inc.
Via
Business Wire
Gilead Sciences Announces Fourth Quarter and Full Year 2025 Financial Results
February 10, 2026
From
Gilead Sciences, Inc.
Via
Business Wire
Gilead’s Second Act: A 2026 Deep Dive into the Transition from Virology to Oncology Powerhouse
February 10, 2026
Via
Finterra
Topics
Economy
Intellectual Property
Should You Buy Gilead Sciences Before Feb. 10?
↗
February 09, 2026
Via
The Motley Fool
Exploring Gilead Sciences's Earnings Expectations
↗
February 09, 2026
Via
Benzinga
Gilead Sciences (GILD) Reports Q4: Everything You Need To Know Ahead Of Earnings
February 08, 2026
Via
StockStory
Topics
Artificial Intelligence
World Trade
FDA Approves Label Update for Kite’s Yescarta® for Relapsed/Refractory Primary Central Nervous System Lymphoma
February 06, 2026
From
Gilead Sciences, Inc.
Via
Business Wire
Here's How Much You Would Have Made Owning Gilead Sciences Stock In The Last 5 Years
↗
February 05, 2026
Via
Benzinga
This Overlooked Biotech Giant Could Surprise Investors This Quarter
February 05, 2026
Via
Barchart.com
1 Safe-and-Steady Stock with Competitive Advantages and 2 Facing Challenges
February 02, 2026
Via
StockStory
Crossroads4Hope Kicks Off Its 25th Year of Caring with the Launch of Free Breast and Colorectal Cancer Resources for Patients and Families Nationwide
February 02, 2026
Via
PRLog
Large Cap Biopharmaceuticals: A Core Position For A Healthcare Portfolio
↗
February 02, 2026
Via
Talk Markets
Topics
Stocks
3 Cash-Producing Stocks with Warning Signs
January 29, 2026
Via
StockStory
The Commonwealth Club Honors Black History Month With Event Featuring Top Black Leaders in AI & Biopharma Discussing the Future of Healthcare
January 29, 2026
Via
Get News
Topics
Artificial Intelligence
Are Wall Street Analysts Predicting Gilead Sciences Stock Will Climb or Sink?
January 29, 2026
Via
Barchart.com
Topics
ETFs
Gilead Sciences to Release Fourth Quarter & Full Year 2025 Financial Results on Tuesday, February 10, 2026
January 27, 2026
From
Gilead Sciences, Inc.
Via
Business Wire
Demystifying Gilead Sciences: Insights From 17 Analyst Reviews
↗
January 27, 2026
Via
Benzinga
Exploring the top movers within the S&P500 index during today's session.
↗
January 23, 2026
Via
Chartmill
Here's How Much $1000 Invested In Gilead Sciences 15 Years Ago Would Be Worth Today
↗
January 22, 2026
Via
Benzinga
Frequently Asked Questions
Is Gilead Sciences publicly traded?
Yes, Gilead Sciences is publicly traded.
What exchange does Gilead Sciences trade on?
Gilead Sciences trades on the Nasdaq Stock Market
What is the ticker symbol for Gilead Sciences?
The ticker symbol for Gilead Sciences is GILD on the Nasdaq Stock Market
What is the current price of Gilead Sciences?
The current price of Gilead Sciences is 147.23
When was Gilead Sciences last traded?
The last trade of Gilead Sciences was at 02/10/26 04:00 PM ET
What is the market capitalization of Gilead Sciences?
The market capitalization of Gilead Sciences is 184.60B
How many shares of Gilead Sciences are outstanding?
Gilead Sciences has 185B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.